Remove Clinical Trials Remove Cosmetics Remove Generic Pharmaceutical Remove Licensing
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment. 2) Xevudy (sotrovimab) Xevudy, a monoclonal antibody treatment for SARS-CoV-2, generated £2.31

Sales 98